Johnson & Johnson <JNJ.N> received grand jury subpoenas in August from the U.S. attorney's office for the Eastern District of New York related to its opioid medication policies, the company said in a regulatory filing on Monday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,